triple negative breast cancer

Showing 1 - 25 of 307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Recruiting
  • Breast Cancer Female
  • +4 more
    • Ho Chi Minh City, Vietnam
    • +1 more
    Oct 16, 2023

    Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • (no location specified)
    Oct 10, 2023

    Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • (no location specified)
    Oct 5, 2023

    Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +13 more
    • (no location specified)
    Aug 29, 2023

    Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Aldesleukin
    • +12 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 9, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

    Not yet recruiting
    • Head and Neck Cancer
    • +9 more
    • (no location specified)
    Jul 12, 2023

    Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • HER2-positive Breast Cancer
    • exosome and ctDNA evaluation
    • Seoul, Korea, Republic of
      Ji-Yeon Kim
    Jul 13, 2023

    Checkpoint Inhibitors in Triple Negative Breast

    Recruiting
    • Triple Negative Breast Cancer
    • Whole Genome Sequencing
    • +7 more
    • Barcelona, Spain
      Vall d'Hebron Institute of Oncology
    Jun 20, 2023

    Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

    Recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 15, 2023

    Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

    Not yet recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • (no location specified)
    Jun 11, 2023

    Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

    Not yet recruiting
    • Advanced Solid Tumor
    • +15 more
    • (no location specified)
    Jun 2, 2023

    Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount

    Recruiting
    • Triple Negative Breast Cancer
    • Nonsmall Cell Lung Cancer
      • Rocky Mount, North Carolina
        Accellacare of Rocky Mount -Dr. Bondy
      May 26, 2023

      Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Dhaka, Bangladesh
        Bangabandhu Sheikh Mujib Medical University
      May 24, 2023

      HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

      Recruiting
      • HER2-positive Breast Cancer
      • +17 more
      • ALX148
      • Fam-Trastuzumab Deruxtecan-Nxki
      • Chicago, Illinois
      • +1 more
      May 19, 2023

      Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Proleukin 1.3 MG Injection
      • (no location specified)
      Apr 6, 2023

      Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

      Recruiting
      • Leptomeningeal Disease
      • +2 more
      • Dendritic Cell Vaccine
      • Tampa, Florida
        Moffitt Cancer Center
      Apr 11, 2023

      Triple Negative Breast Cancer Trial (Ociperlimab, Tislelizumab, Paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • (no location specified)
      Mar 30, 2023

      Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Cryoablation
      • Cryoablation combined with PD1 Inhibitor
      • (no location specified)
      Mar 28, 2023